A National Cancer Institute of Canada Clinical Trials Group Study – IND.135: Phase I/II study of irinotecan (camptosar), oxaliplatin and raltitrexed (tomudex) (COT) in patients with advanced colorectal cancerJean A. Maroun, G. Chiritescu, D Lister et al.|European Journal of Cancer|2005Cited by 9
Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphomaJonathan C. Yau, Glenwood Goss, Colin Germond et al.|American Journal of Hematology|1998Cited by 6
Encouraging results from a phase I study of capecitabine (X), irinotecan (I) and oxaliplatin (O) as first-line therapy in patients (pts) with metastatic colorectal cancer (MCRC)Jean A. Maroun, G. Chiritescu, Derek J. Jonker et al.|Journal of Clinical Oncology|2007Cited by 4
A phase I/II study of capecitabine (X), irinotecan (I) and oxaliplatin (O) as first-line therapy in patients (pts) with advanced or metastatic colorectal cancer (MCRC)Jean A. Maroun, G. Chiritescu, C. Cripps et al.|Journal of Clinical Oncology|2006Cited by 2